Kevin DeGeeter
Stock Analyst at Ladenburg Thalmann & Co.
(4.76)
# 655
Out of 5,126 analysts
422
Total ratings
37.9%
Success rate
18.2%
Average return
Main Sectors:
Stocks Rated by Kevin DeGeeter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVCR NovoCure | Reiterated: Buy | $30 → $31 | $11.99 | +158.55% | 14 | Nov 10, 2026 | |
| URGN UroGen Pharma | Reiterated: Buy | $43 → $62 | $26.10 | +137.55% | 2 | Nov 5, 2026 | |
| APRE Aprea Therapeutics | Initiated Coverage: Buy | $2 | $0.4445 | +349.94% | 1 | Oct 14, 2026 | |
| CLRB Cellectar Biosciences | Reiterated: Buy | $10 | $1.21 | +726.45% | 14 | Aug 14, 2026 | |
| ELTX Elicio Therapeutics | Initiated Coverage: Buy | $20 → $12 | $1.63 | +636.20% | 2 | Jun 18, 2026 | |
| TRAW Traws Pharma | Downgraded: Hold | n/a | $0.25 | - | 2 | Jun 15, 2026 | |
| DCOY Decoy Therapeutics | Initiated Coverage: Buy | $2.5 | $1.09 | +129.36% | 1 | Jan 23, 2026 | |
| ORIC ORIC Pharmaceuticals | Reiterated: Buy | $15 | $9.00 | +66.67% | 21 | Nov 14, 2025 | |
| CRDF Cardiff Oncology | Reiterated: Buy | $19 | $0.7653 | n/a | 2 | Nov 10, 2025 | |
| NXTC NextCure | Upgraded: Buy | $18 | $5.98 | n/a | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.2 → $3 | $1.71 | n/a | 10 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $4.46 | n/a | 1 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 → $59 | $28.33 | n/a | 18 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $37 | $4.28 | n/a | 9 | Apr 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $7 | $0.000001 | n/a | 13 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $17 | $1.94 | n/a | 2 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $24 | $15.96 | n/a | 21 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $141 → $125 | $25.70 | n/a | 20 | Jan 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $1.10 | n/a | 19 | Dec 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.5 → $5 | $0.000001 | n/a | 8 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.02 | n/a | 23 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $3.24 | n/a | 1 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $13.82 | n/a | 16 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $8.10 | n/a | 18 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $2.91 | n/a | 6 | Jul 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $59.45 | n/a | 24 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.35 | n/a | 6 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $32.72 | n/a | 20 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.5 | $0.000001 | n/a | 21 | Jun 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $4.07 | n/a | 1 | May 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $0.6702 | n/a | 1 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $17.30 | n/a | 13 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.48 | n/a | 9 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.98 | n/a | 22 | Jun 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.26 | n/a | 12 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $1.11 | n/a | 7 | May 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3 | $0.000001 | n/a | 1 | Jul 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $7.5 | $13.19 | n/a | 2 | Jun 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $13.65 | n/a | 2 | Apr 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.365 | n/a | 2 | Feb 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $5.72 | n/a | 6 | Feb 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $0.9764 | n/a | 1 | Jan 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 3 | Nov 13, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $45 | $0.6882 | n/a | 1 | Oct 31, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $75 | $122.27 | n/a | 9 | Oct 30, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $0.5915 | n/a | 4 | Aug 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $121 | $468.11 | n/a | 2 | Apr 4, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $7.65 | n/a | 1 | Feb 28, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $86 | $169.73 | n/a | 2 | Jan 26, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.5 → $3 | $0.0001 | n/a | 2 | Nov 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $0.0008 | n/a | 1 | Oct 1, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.75 → $2.75 | $0.000001 | n/a | 2 | Aug 8, 2013 |
NovoCure
Nov 10, 2026
Reiterated: Buy
Price Target: $30 → $31
Current: $11.99
Upside: +158.55%
UroGen Pharma
Nov 5, 2026
Reiterated: Buy
Price Target: $43 → $62
Current: $26.10
Upside: +137.55%
Aprea Therapeutics
Oct 14, 2026
Initiated Coverage: Buy
Price Target: $2
Current: $0.4445
Upside: +349.94%
Cellectar Biosciences
Aug 14, 2026
Reiterated: Buy
Price Target: $10
Current: $1.21
Upside: +726.45%
Elicio Therapeutics
Jun 18, 2026
Initiated Coverage: Buy
Price Target: $20 → $12
Current: $1.63
Upside: +636.20%
Traws Pharma
Jun 15, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.25
Upside: -
Decoy Therapeutics
Jan 23, 2026
Initiated Coverage: Buy
Price Target: $2.5
Current: $1.09
Upside: +129.36%
ORIC Pharmaceuticals
Nov 14, 2025
Reiterated: Buy
Price Target: $15
Current: $9.00
Upside: +66.67%
Cardiff Oncology
Nov 10, 2025
Reiterated: Buy
Price Target: $19
Current: $0.7653
Upside: n/a
NextCure
Nov 7, 2025
Upgraded: Buy
Price Target: $18
Current: $5.98
Upside: n/a
Oct 30, 2025
Reiterated: Buy
Price Target: $5.2 → $3
Current: $1.71
Upside: n/a
Apr 19, 2022
Initiated Coverage: Buy
Price Target: $22
Current: $4.46
Upside: n/a
Apr 19, 2022
Reiterated: Buy
Price Target: $63 → $59
Current: $28.33
Upside: n/a
Apr 1, 2022
Reiterated: Buy
Price Target: $45 → $37
Current: $4.28
Upside: n/a
Mar 30, 2022
Reiterated: Buy
Price Target: $9 → $7
Current: $0.000001
Upside: n/a
Mar 30, 2022
Reiterated: Buy
Price Target: $19 → $17
Current: $1.94
Upside: n/a
Feb 25, 2022
Reiterated: Buy
Price Target: $30 → $24
Current: $15.96
Upside: n/a
Jan 25, 2022
Reiterated: Buy
Price Target: $141 → $125
Current: $25.70
Upside: n/a
Dec 27, 2021
Reiterated: Buy
Price Target: $14
Current: $1.10
Upside: n/a
Nov 16, 2021
Reiterated: Buy
Price Target: $5.5 → $5
Current: $0.000001
Upside: n/a
Oct 1, 2021
Downgraded: Hold
Price Target: n/a
Current: $1.02
Upside: n/a
Sep 20, 2021
Initiated Coverage: Buy
Price Target: $30
Current: $3.24
Upside: n/a
Jul 20, 2021
Reiterated: Buy
Price Target: $7
Current: $13.82
Upside: n/a
Jul 13, 2021
Reiterated: Buy
Price Target: $18
Current: $8.10
Upside: n/a
Jul 8, 2021
Reiterated: Buy
Price Target: $18
Current: $2.91
Upside: n/a
Jun 30, 2021
Reiterated: Hold
Price Target: n/a
Current: $59.45
Upside: n/a
Jun 28, 2021
Downgraded: Hold
Price Target: n/a
Current: $13.35
Upside: n/a
Jun 28, 2021
Reiterated: Buy
Price Target: $25
Current: $32.72
Upside: n/a
Jun 16, 2021
Reiterated: Buy
Price Target: $5.5
Current: $0.000001
Upside: n/a
May 26, 2021
Initiated Coverage: Buy
Price Target: $25
Current: $4.07
Upside: n/a
Apr 29, 2021
Initiated Coverage: Buy
Price Target: $17
Current: $0.6702
Upside: n/a
Mar 4, 2021
Rated: Hold
Price Target: n/a
Current: $17.30
Upside: n/a
Mar 4, 2021
Rated: Hold
Price Target: n/a
Current: $2.48
Upside: n/a
Jun 15, 2020
Rated: Hold
Price Target: n/a
Current: $9.98
Upside: n/a
Feb 24, 2020
Rated: Hold
Price Target: n/a
Current: $4.26
Upside: n/a
May 9, 2019
Rated: Buy
Price Target: $3
Current: $1.11
Upside: n/a
Jul 10, 2018
Initiated Coverage: Buy
Price Target: $3
Current: $0.000001
Upside: n/a
Jun 13, 2018
Reiterated: Buy
Price Target: $13 → $7.5
Current: $13.19
Upside: n/a
Apr 10, 2017
Reiterated: Buy
Price Target: $13
Current: $13.65
Upside: n/a
Feb 14, 2017
Downgraded: Hold
Price Target: n/a
Current: $0.365
Upside: n/a
Feb 8, 2017
Upgraded: Hold
Price Target: n/a
Current: $5.72
Upside: n/a
Jan 4, 2017
Upgraded: Buy
Price Target: n/a
Current: $0.9764
Upside: n/a
Nov 13, 2014
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Oct 31, 2014
Rated: Sell
Price Target: $45
Current: $0.6882
Upside: n/a
Oct 30, 2014
Rated: Buy
Price Target: $75
Current: $122.27
Upside: n/a
Aug 7, 2014
Rated: Buy
Price Target: $3
Current: $0.5915
Upside: n/a
Apr 4, 2014
Rated: Hold
Price Target: $121
Current: $468.11
Upside: n/a
Feb 28, 2014
Initiated Coverage: Hold
Price Target: n/a
Current: $7.65
Upside: n/a
Jan 26, 2014
Rated: Buy
Price Target: $86
Current: $169.73
Upside: n/a
Nov 7, 2013
Reiterated: Buy
Price Target: $7.5 → $3
Current: $0.0001
Upside: n/a
Oct 1, 2013
Upgraded: Buy
Price Target: n/a
Current: $0.0008
Upside: n/a
Aug 8, 2013
Reiterated: Buy
Price Target: $1.75 → $2.75
Current: $0.000001
Upside: n/a